We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+8.49%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.49B
AUM Growth
+$162M
Cap. Flow
-$68.3M
Cap. Flow %
-1.96%
Top 10 Hldgs %
23.61%
Holding
339
New
21
Increased
97
Reduced
142
Closed
20

Top Buys

Rank Stock Value
1
MBLY icon
Mobileye
MBLY
+$30.6M
2
NEOG icon
Neogen
NEOG
+$9.45M
3
PATK icon
Patrick Industries
PATK
+$7.7M
4
DV icon
DoubleVerify
DV
+$7.46M
5
SNOW icon
Snowflake
SNOW
+$7.44M

Top Sells

Rank Stock Value
1
HEI icon
HEICO Corp
HEI
+$27.6M
2
BILL icon
BILL Holdings
BILL
+$21.4M
3
COLL icon
Collegium Pharmaceutical
COLL
+$10.6M
4
DOOR
MASONITE INTERNATIONAL CORP
DOOR
+$9.24M
5
PR
Permian Resources
PR
+$9.15M

Sector Composition

Rank Sector Weight
1 Technology 23.77%
2 Healthcare 17.32%
3 Financials 15.38%
4 Consumer Discretionary 14.42%
5 Industrials 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
226
DELISTED
Apellis Pharmaceuticals
APLS
$5.45M 0.16%
+92,660
New +$5.91M
ASTE icon
227
Astec Industries
ASTE
$989M
$5.45M 0.16%
124,597
+11,956
+11% +$446K
BLFS icon
228
BioLife Solutions
BLFS
$1.7B
$5.45M 0.16%
293,587
+100
+0% +$1.75K
HELE icon
229
Helen of Troy
HELE
$682M
$5.44M 0.16%
47,243
-2,845
-6% -$340K
ZUO
230
DELISTED
Zuora, Inc.
ZUO
$5.38M 0.15%
590,128
+196
+0% +$1.71K
ADMA icon
231
ADMA Biologics
ADMA
$2.22B
$5.38M 0.15%
815,044
-67,939
-8% -$371K
LGF.B
232
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$5.24M 0.15%
562,383
+195
+0% +$1.8K
EFSC icon
233
Enterprise Financial Services Corp
EFSC
$2.4B
$5.2M 0.15%
128,325
-7,781
-6% -$319K
HZO icon
234
MarineMax
HZO
$1.16B
$5.2M 0.15%
156,344
-9,264
-6% -$297K
RBA icon
235
RB Global
RBA
$16.6B
$5.19M 0.15%
68,120
+55
+0.1% +$3.84K
IONS icon
236
Ionis Pharmaceuticals
IONS
$9.21B
$5.14M 0.15%
118,598
+10,774
+10% +$514K
SNDX icon
237
Syndax Pharmaceuticals
SNDX
$1.81B
$4.67M 0.13%
196,079
+46
+0% +$1.03K
KNSA icon
238
Kiniksa Pharmaceuticals
KNSA
$6.07B
$4.66M 0.13%
+236,045
New +$4.61M
ULCC icon
239
Frontier Group Holdings
ULCC
$1.59B
$4.65M 0.13%
573,886
-34,539
-6% -$224K
SRPT icon
240
Sarepta Therapeutics
SRPT
$1.92B
$4.6M 0.13%
35,514
-2,949
-8% -$361K
ALTM
241
DELISTED
Arcadium Lithium plc
ALTM
$4.43M 0.13%
+1,028,490
New +$5.16M
ATSG
242
DELISTED
Air Transport Services Group
ATSG
$3.99M 0.11%
289,969
-17,489
-6% -$252K
SRI icon
243
Stoneridge
SRI
$193M
$3.94M 0.11%
213,596
-12,586
-6% -$223K
LUCK
244
Lucky Strike Entertainment
LUCK
$897M
$3.72M 0.11%
271,627
+64
+0% +$826
INMD icon
245
InMode
INMD
$870M
$3.69M 0.11%
170,830
-114,722
-40% -$2.57M
MNRO icon
246
Monro
MNRO
$365M
$2.93M 0.08%
92,915
+39
+0% +$1.21K
CHRS icon
247
Coherus Oncology
CHRS
$187M
$2.43M 0.07%
1,016,455
-73,506
-7% -$181K
MANH icon
248
Manhattan Associates
MANH
$11.4B
$2.13M 0.06%
8,510
– –
WCC
249
WESCO International
WCC
$17.8B
$1.75M 0.05%
10,218
+1,300
+15% +$215K
NOVT icon
250
Novanta
NOVT
$6.34B
$1.54M 0.04%
8,838
– –
8 9
10
11 12

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Peregrine Capital Management held 339 positions worth $3.49B, up 4.9% from $3.33B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Peregrine Capital Management's Q1 2024 filing shows 21 new, 97 increased, 142 reduced and 20 closed positions. Its largest new stake was Mobileye: 1,078,809 shares worth $34.7M. The largest sale was HEICO Corp, an estimated $27.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q1 2024 buy was Mobileye: 1,078,809 shares worth $34.7M.
  • Peregrine Capital Management added most to DoubleVerify in Q1 2024, an estimated $7.46M increase.
  • Peregrine Capital Management's biggest Q1 2024 reduction was HEICO Corp, cutting an estimated $27.6M.
  • Peregrine Capital Management fully exited Collegium Pharmaceutical in Q1 2024, selling an estimated $10.6M.
  • Peregrine Capital Management's ten largest holdings make up 24% of its $3.49B portfolio in Q1 2024.
  • Peregrine Capital Management opened 21 new positions and closed 20 in Q1 2024.
  • Peregrine Capital Management's portfolio value rose 4.9% quarter-over-quarter to $3.49B.

Based on Peregrine Capital Management's 13F filing for Q1 2024, filed 26 Apr 2024.